* Sensus Healthcare Inc SRTS.OQ SRTS.O is expected
to show a
rise in quarterly revenue when it reports results on May 9 for
the period ending March 31 2024
* The Boca Raton Florida-based company is expected to
report a
20.7% increase in revenue to $4.12 million from $3.41 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Sensus Healthcare Inc is
for a
loss of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sensus
Healthcare
Inc is $7.00, above its last closing price of $3.78.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 0.14 0.12 0.26 Beat 113.1
Sep. 30 2023 -0.01 -0.02 -0.09 Missed -400
Jun. 30 2023 -0.08 -0.08 -0.02 Beat 73.7
Mar. 31 2023 0.12 0.13 -0.12 Missed -193.7
Dec. 0.25 0.23 0.17 Missed -26.1
31 2022
Sep. 30 2022 0.12 0.13 0.11 Missed -12.7
Jun. 30 2022 0.16 0.13 0.21 Beat 59.1
Mar. 31 2022 0.55 0.33 0.19 Missed -42.4
This summary was machine generated May 8 at 01:54 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)